NIMI
WST icon

Natixis Investment Managers International’s West Pharmaceutical WST Stock Holding History

Natixis Investment Managers International’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,102
Closed -$333K – 468
2022
Q2 		$333K Buy
1,102
+182
+20% +$59.2K 0.01% 346
2022
Q1 		$377K Buy
+920
New +$360K 0.01% 338

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Natixis Investment Managers International's WST Position: Q3 2022 in Review

Natixis Investment Managers International sold out of West Pharmaceutical (WST) in Q3 2022, closing a stake of 1,102 shares — an estimated $333K sold.

Natixis Investment Managers International first reported a position in WST in Q1 2022 and held it in 2 quarters. The position peaked at $377K in Q1 2022. 638 funds tracked by Wall St. Rank hold WST as of Q3 2022.

  • Natixis Investment Managers International reported no remaining West Pharmaceutical position as of Q3 2022 after selling out during the quarter.
  • Natixis Investment Managers International sold 1,102 West Pharmaceutical shares in Q3 2022, an estimated $333K.
  • Natixis Investment Managers International first reported a position in West Pharmaceutical in Q1 2022 and held it in 2 quarters.
  • Natixis Investment Managers International's West Pharmaceutical position peaked at $377K in Q1 2022.
  • 638 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2022.

Based on Natixis Investment Managers International's 13F filing for Q3 2022, filed 14 Nov 2022.